Novartis Recalls Ritalin Tablets Due to Incorrect Medication Guide Labeling
Novartis is recalling Ritalin tablets because the attached Medication Guide contained information for the sustained-release version. The recall is limited to a specific lot distributed nationwide and in Puerto Rico.
- Product
- RITALIN — RITALIN (METHYLPHENIDATE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide